Amphiregulin Promotes BAX Inhibition and Resistance to Gefitinib in Non-small-cell Lung Cancers

Documenti analoghi

• Amphiregulin Promotes Resistance to Gefitinib in NonSmall Cell Lung Cancer Cells by Regulating Ku70 Acetylation
  di: Busser, Benoît, et al.
  Pubblicazione: (2009)
• Cooperation of amphiregulin and insulin-like growth factor-1 inhibits Bax- and Bad-mediated apoptosis via a protein kinase C-dependent pathway in non-small cell lung cancer cells
  di: Hurbin, Amandine, et al.
  Pubblicazione: (2005)
• Synergistic activity of vorinostat combined with gefitinib but not with sorafenib in mutant KRAS human non-small cell lung cancers and hepatocarcinoma
  di: Jeannot, Victor, et al.
  Pubblicazione: (2016)
• TAZ sensitizes EGFR wild-type non-small-cell lung cancer to gefitinib by promoting amphiregulin transcription
  di: Yuan, Weiwei, et al.
  Pubblicazione: (2019)
• The Multifaceted Roles of Copper in Cancer: A Trace Metal Element with Dysregulated Metabolism, but Also a Target or a Bullet for Therapy
  di: Lelièvre, Pierre, et al.
  Pubblicazione: (2020)